FreeTCCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial February 03, 2014Vol.37 No.01
Conversation with The Cancer LetterFree Seffrin To Retire After Restructuring ACS January 24, 2014Vol.40 No.04By Paul Goldberg
Free Secretive Contract Manufacturing Arrangements Complicate Solutions to Shortages of Generics January 03, 2014Vol.40 No.01
